According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is -$1.89. In 2012 the company made an earnings per share (EPS) of -$2.99.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$1.89 | |
2012 | -$2.99 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -845.25% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | -198.41% | ๐บ๐ธ USA |
AbbVie ABBV | $3.68 | -294.74% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | -387.26% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | -205.03% | ๐ฌ๐ง UK |
BioMarin Pharmaceutical BMRN | $0.78 | -141.20% | ๐บ๐ธ USA |